Delivery Order SPE2DB24D2105-SPE2DB25FAPYG
Award Date 7/18/25
Potential Completion Date 8/8/25
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,727.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 420 mg tablets (28-count package), with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is being performed from the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's...
- This is a $33,865.10 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,188,793 units of the drug Imbruvica 420 mg tablets. The contract is a firm fixed-price delivery order with a period of performance through May 30, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- This is a $14,645.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imbruvica 420 mg tablets. The order has an ultimate completion date of September 17, 2024. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range of pharmaceutical products and medical supplies to support military treatment...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product Imbruvica 280 mg tablet. The contract has a ceiling value of $14,645.34 and a performance period through April 26, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of IMBRUVICA 420 mg tablets to support military and government healthcare programs. The $7,575.75 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply Imbruvica 140 mg tablets. The $7,322.67 order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides a range of pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order is part of Amerisourcebergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of IMBRUVICA 420 MG TABLET 28S. The fixed-price contract has a ceiling value of $37,878.75 and a performance period through July 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This federal contract award, valued at $7,575.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imbruvica 420 mg tablets, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of May 14, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide IMBRUVICA 280 MG TABLET 28S. The contract has a potential value of $7,322.67 and a completion date of March 4, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of up to $999,999,999.00 and a performance period...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $7,322.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The order is for the supply of 420 mg Imbruvica tablets, a prescription medication, with a completion date of July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025,...